SBIR/STTR Research Award

A multiscale computational tool to simulate the PK of orally-administered drugs in the human GI tract

Award identifier 6a9ace300ad44faadc458acbb3eb355a51b970095f3f695d633fed2dada56ceaAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CFD Research Corporation
Proposal award date
2019-05-01
Contract end date
2020-10-31
UEI
V3KCP1HNFM33
Solicitation number
PA18-574
Topic code
400

Research abstract

A multiscale computational tool to simulate the PK of orally administered drugs in the human GI tract Project Summary AbstractMost FDA approved drugs are administered orallydespite the complex process of oral drug absorption that is difficult to analyze experimentallyOral bioavailability is dependent on the interplay between multiple and simultaneous processes that are dependent on both the drug compound as well as the physiological and anatomical states of the userDue to this complexitycomputational models have emerged as a tool to integrate these factors in an attempt to mechanistically capture and predict the process of oral absorption in a robust and accurate mannerThe current predictive models are generallyD compartmental models and are thus limited by simplified physiological characteristics of the gastrointestinal tractGITby semi empirical or specific analytical solutions of dissolution profilesand by insufficient descriptions of interactions between delivery vehicles and the GITIn particularthe absorption can be incorrectly modelled using theD models forisome drug classesunder the BCS schemeiifor GITwhose sizes are significantly different from the median human andiiifor drugsthat are meant to target specific regionsfor instancethe drugs used to treat some colon cancerby incorrectly predicting the absorption in other regionsIn this projectwe propose to develop an efficient and spatially accurate computational tool to simulate the dissolutiontransportLiberationAbsorptionDistributionMetabolismEliminationand ToxicityLADME Tof orally administered drugs in the human GIT at the enzymedelivery vehicleintestine tissueand GIT levelsThis will be further combined with the compartmental model at the whole body level to predict systemic pharmacokineticsIn Phase Ithe multiscale computational tool will be constructed by integrating the spatially accurate first principles driven highfidelity drug transportdissolution and absorption model in the human stomach and GITmechanistic drug release modelsand the multi layer intestine physiologically based pharmacokineticslumenenterocyteand blood layersmodelsThese will be accomplished using the recently demonstrated CFD Research Corporation s spatially accurate Q D frameworkIn Phase IIwe willitest and validate the models for drug transport and absorption physics for theBCS classes of drugsiimorph the GIT to create variants corresponding to diseased specimens and different anatomical sizesiiiperform and validate the spatially accurate drug absorption simulations for these new GIT variantsivobtain the PK parameters and perform the drug absorption simulations for infants and childrenvlink the Q D GUT model to the whole body PK modelandviuse this multiscale modelto optimize specific casesincluding the drug delivery to target regionsThe multiscale software developed in this project will provide a powerful virtual platform in investigating LADME Tfacilitating in vitro in vivo scalingdesigning and developing targeted oral drug delivery systemsand evaluating safety and efficacy of oral drug productsUltimatelythe proposed tool will be developed into a commercial product to meet urgent demands from pharmaceutical and biomedical industries Project NarrativeThe novel software tool proposed in this project will provide an efficient and spatio temporally accurate multiscale computational platform to virtually testdesignand develop oral drug productsThis will be achieved by investigating interactions between drug delivery systems and the human physiological systems from enzyme levels to whole body levelsand by revealing key aspects affecting oral drug absorption and consequent therapeutic or toxic effectsThe developed tool will meet urgent demands from pharmaceutical and biomedical industries by accelerating drug discovery and development processesby facilitating translational applications from bench to bedsideby increasing success rates of new drug productsand by ultimately helping reduce the health care burdens on society

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

947 SBIR/STTR records share this UEI (1987–2026). Reported award amounts total $350,893,199. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, National Science Foundation, Department of Commerce, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.